Related Party Transactions (Tables)

12 Months Ended

Mar. 31, 2022

Transactions with Equity Method Investees

In the ordinary course of business, we are involved in related party transactions with equity method investees. These related party transactions primarily relate to the licensing and distribution of the Company's films and television programs and the lease of a studio facility owned by an equity-method investee, for which the impact on the Company's consolidated balance sheets and consolidated statements of operations is as follows (see Note 1 and Note 5):


	March 31,
	2022		2021
	(Amounts in millions)
Consolidated Balance Sheets
Accounts receivable	$	13.1	$	9.4
Investment in films and television programs(1)	1.6		—
Other assets, noncurrent(1)(2)	44.2		2.4
Total due from related parties	$	58.9	$	11.8

Accounts payable and accrued liabilities(1)(3)	$	22.2	$	15.4
Participations and residuals, current	5.9		7.6
Participations and residuals, noncurrent	1.1		1.2


Other liabilities(1)	38.3		—
Total due to related parties	$	67.5	$	24.2

	Year Ended March 31,
	2022		2021		2020
	(Amounts in millions)
Consolidated Statements of Operations
Revenues	$	4.1	$	7.2	$	4.6
Direct operating expense	$	6.5	$	10.8	$	13.8
Distribution and marketing expense	$	0.2	$	0.2	$	—
General and administrative expense(4)	$	—	$	—	$	(1.1)
Interest and other income	$	3.1	$	2.9	$	1.7

__________________________________

(1)During the year ended March 31, 2022, the Company entered into certain operating leases related to a studio facility owned by an equity-method investee. Amounts related to these leases are included in investment in films and television programs, other assets - noncurrent, accounts payable and accrued liabilities and other liabilities in the consolidated balance sheet at March 31, 2022.

(2)During the years ended March 31, 2022, 2021, and 2020, the Company made loans (including accrued interest) of $3.0 million, $2.9 million and $12.5 million, respectively, to certain of its equity method investees, of which no amounts, none and $3.3 million, respectively, are included in other assets, noncurrent in the Company's consolidated balance sheets (net of equity interests losses applied against such loans), and included in the table above.

(3)Amounts primarily represent production related advances due to certain of its equity method investees.

(4)In the year ended March 31, 2020, amounts primarily represent reimbursement for certain shared services for equity method investees.